Research and Grants | The Cure Starts Now

The Cure Starts Now has funded $17,818,037 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 110 grants at over 100 hospitals in 15 countries.


Oncoceutics ONC201 - $100,000

Amount
$100,000.00
Date
December 2019

Expansion of the ONC201 Compassionate Use.

University of Sydney - $100,000

Amount
$100,000.00
Date
November 2019

Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.

University of Michigan Hospitals - $157,856

Amount
$157,856.00
Date
November 2019

Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG

Dayton Children's Hospital - $69,600

Amount
$69,600.00
Date
November 2019

Responses of distinct cell populations to PDGFRA inhibitors in diffuse intrinsic pontine glioma.

Institute of Cancer Research - $121,863

Amount
$121,863.00
Date
November 2019

Targeting Top3A-Amplified DIPG cells by Sirtuin inhibition.

Bambino Gesu Children's Hospital - $49,803

Amount
$49,803.00
Date
August 2019

Using imaging mass cytometry to identify next generation imaging biomarkers in PHGG and DIPG.

Telethon Kids Institute - $49,512

Amount
$49,512.00
Date
August 2019

Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.

Oncoceutics ONC201 - Phase II - $83,333

Amount
$83,333.00
Date
May 2019

Expansion of the ONC201 Compassionate Use.